Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02939339 · ClinicalTrials.gov registry record · Early Phase 1
Theta Burst TMS as a Tool to Change Smoking Behavior
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT02939339 is a Early Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 15 participants.
The verdict
NCT02939339, a Early Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether transcranial magnetic stimulation (TMS) is an effective treatment in decreasing craving in individuals who habitually smoke cigarettes. The study consists of six total visits to MUSC; one for the consent process, two that will include MRI scans, and five that will include TMS administration. Compensation will be provided for each visit.
Interventions
- DEVICE continuous theta burst stimulation (real)
- DEVICE continuous theta burst stimulation (sham)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-08-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02939339
The ClinicalTrials.gov registry entry for NCT02939339 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which continuous theta burst stimulation (real) is the first listed.
NCT02939339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02939339 about?
NCT02939339 is a clinical study titled "Theta Burst TMS as a Tool to Change Smoking Behavior". The goal of this study is to determine whether transcranial magnetic stimulation (TMS) is an effective treatment in decreasing craving in individuals who habitually smoke cigarettes. The study consists of six total visits to MUSC; one for the consent process, two that will include MRI scans, and fiv...
What is the current status of trial NCT02939339?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2015-10. Estimated completion is 2017-08-01.
What interventions are being tested in trial NCT02939339?
The interventions under investigation include: continuous theta burst stimulation (real) (DEVICE), continuous theta burst stimulation (sham) (DEVICE).
Who is sponsoring clinical trial NCT02939339?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.